Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

EMA recommends orphan drug status for 4SC's resminostat

July 26, 2011

Orally active histone deacetylase inhibitor displays potent antitumor activity in vivo

July 26, 2011

New cyclin-dependent kinase 9 inhibitors presented by Vichem Chemie Kutato

July 26, 2011

Novartis claims novel agents for treatment of cancer

July 26, 2011

CHMP issues opinion on Zytiga in prostate cancer

July 25, 2011

Afinitor recommended for new European approval

July 25, 2011

Tarceva recommended for E.U. approval as first-line therapy in distinct type of lung cancer

July 25, 2011

Celgene discloses novel inhibitors of TNF-alpha production and/or phosphodiesterase 4

July 25, 2011

Cellceutix cleared to conduct phase I trial of anticancer drug

July 22, 2011

NanoCarrier and Orient Europharma commence phase II study of Nanoplatin

July 22, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...